0

Monday, March 2, 2015

Adozelesin

Adozelesin is an experimental antitumor drug of the duocarmycin class.[1] It binds to and alkylates DNA, resulting in a reduction of both cellular and simian virus 40 (SV40) DNA replication which ultimately reduces the rate of cancer growth.[2]
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)